US Senator Calls Out Big Pharma Over Improper Inhaler Patents

AstraZeneca, Boehringer Ingelheim, GSK And Teva Urged To Remove Patents From Orange Book

 
• By Urtė Fultinavičiūtė
  
Hand holding blue inhaler on orange background
The FTC challenged over 100 patents last year • Source: Shutterstock

More from Legal & IP

More from Generics Bulletin